Aktienanalyse wird geladen …
MCK · NYSE · Medical Distribution · USA
869,14 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 403,43 Mrd. | 4,76 Mrd. | 38,38 $ | 124,1 Mio. | 0,3 Mio · 0,2 % | 4,3 Mio · 3,5 % | 3,6 % | 1,2 % | 46,08 $ | 1,99 $ | 3,17 $ |
| 2024 | 359,05 Mrd. | 3,3 Mrd. | 25,72 $ | 128,1 Mio. | 0,3 Mio · 0,2 % | 6,3 Mio · 4,9 % | 3,7 % | 0,9 % | 43,31 $ | 1,76 $ | 2,75 $ |
| 2023 | 308,95 Mrd. | 3 Mrd. | 22,39 $ | 134,1 Mio. | 0,2 Mio · 0,2 % | 8,3 Mio · 6,2 % | 4,2 % | 1 % | 28,96 $ | 1,36 $ | 2,40 $ |
| 2022 | 276,71 Mrd. | 3,56 Mrd. | 25,03 $ | 142,2 Mio. | 0,2 Mio · 0,1 % | 12,1 Mio · 8,5 % | 4,5 % | 1,3 % | 33,54 $ | 1,14 $ | 2,09 $ |
| 2021 | 263,97 Mrd. | 1,11 Mrd. | 7,23 $ | 154,1 Mio. | 0,2 Mio · 0,1 % | — | 5 % | 0,4 % | 26,26 $ | 1,04 $ | 1,83 $ |
| 2020 | 238,23 Mrd. | -4,54 Mrd. | -28,26 $ | 160,6 Mio. | 0,2 Mio · 0,1 % | — | 5,1 % | -1,9 % | 25,47 $ | 0,94 $ | 1,67 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 105,38 Mrd. | 614 Mio. | 5,15 $ | 119,2 Mio. | 3,5 % | 0,6 % | -2,79 $ |
| Q1 2026 | 96,3 Mrd. | 1,68 Mrd. | 13,55 $ | 122,7 Mio. | 4,2 % | 1,8 % | 26,67 $ |
| Q4 2025 | 106,16 Mrd. | 1,19 Mrd. | 9,59 $ | 123,7 Mio. | 3,5 % | 1,1 % | 9,09 $ |
| Q3 2025 | 103,15 Mrd. | 1,11 Mrd. | 8,92 $ | 124,4 Mio. | 3,4 % | 1,1 % | 18,60 $ |
| Q2 2025 | 97,83 Mrd. | 784 Mio. | 6,25 $ | 125,5 Mio. | 3,4 % | 0,8 % | -8,20 $ |
| Q1 2025 | 90,82 Mrd. | 1,26 Mrd. | 10,15 $ | 125,9 Mio. | 4 % | 1,4 % | 61,07 $ |
| Q4 2024 | 95,29 Mrd. | 879 Mio. | 6,94 $ | 126,6 Mio. | 3,5 % | 0,9 % | -19,82 $ |
| Q3 2024 | 93,65 Mrd. | 241 Mio. | 1,86 $ | 129,3 Mio. | 3,5 % | 0,3 % | 15,19 $ |
Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?
Why McKesson (MCK) Dipped More Than Broader Market Today
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date
3 Reasons MCK Has Explosive Upside Potential
McKesson Corporation is a healthcare services company that supports the movement of medicines, medical supplies, and related services across the healthcare system. McKesson Corporation serves pharmacies, hospitals, long-term care facilities, clinics, and other care providers through its pharmaceutical distribution, medical-surgical, oncology, and prescription technology businesses. Its North American Pharmaceutical operations handle branded, generic, specialty, biosimilar, and over-the-counter products, while its Prescription Technology Solutions segment helps connect patients, pharmacies, payers, and biopharma companies through software-enabled workflows. The company’s Medical-Surgical Solutions business supplies healthcare organizations with equipment, consumables, and logistics support. Based in Irving, Texas, McKesson Corporation plays a central role in healthcare infrastructure by helping customers manage access, distribution, and operational efficiency across the care continuum.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest MCK und jede andere Aktie unbegrenzt.